About Mito Peptides: our mission, editorial approach, and research methodology.
Mito Peptides covers pre-clinical research on mitochondria-targeted peptides and longevity biology — SS-31 (elamipretide), MOTS-c, humanin, and related mitochondria-derived peptides. The focus is on what controlled research shows about how these compounds interact with mitochondrial function, cellular energy, and aging biology.
Articles synthesize findings from published pre-clinical studies. We distinguish between in-vitro evidence, rodent model findings, and any available larger-animal or early human-use research contexts. When the mechanistic picture is incomplete, we note it. When researchers debate interpretations, we cover the debate.
We cover topics across mitochondria targeted peptides, SS-31 peptide research, MOTS-c aging research, humanin peptide longevity. Articles are written for researchers, informed readers, and people with a genuine interest in the underlying science.
All content is for informational and research purposes only. This site does not provide medical advice, diagnoses, or treatment recommendations. Peptides discussed are investigational research compounds. Always consult qualified healthcare professionals before making any health decisions.
Questions or feedback? This site does not currently offer a public contact form.